cnto 3157
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2010 (NCT01195207)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Toll-like receptor 3ANTAGONIST
TLR3 antagonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- cnto 3157
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02008279 | Phase 1 | Dec 1, 2013 | Johnson and Johnson |
| NCT01704040 | Phase 1 | Oct 1, 2012 | Johnson and Johnson |
| NCT01195207 | Phase 1 | Jun 1, 2010 | Centocor |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 2 | 2 | 1 | 2012 |
| Centocor | For profit | 1 | 1 | 1 | 2010 |
2 organizations
Page 1 / 1